FDA Approved: TAZVERIK — Original Application (Epizyme, Inc.)

View source ↗

Summary

The FDA approved the original application for TAZVERIK (tazemetostat) by Epizyme, Inc. for epithelioid sarcoma, marking the first approved indication for this E…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epithelioid Sarcoma

Drugs mentioned

• TAZVERIK (TAZEMETOSTAT)

Snippet

ORIG AP for TAZVERIK (TAZEMETOSTAT)